Key Events This Week
16 Mar: Valuation grade upgraded to fair amid elevated multiples
17 Mar: Stock hits 52-week low of Rs.36.1
18 Mar: Price rebounds sharply by 3.91%
19 Mar: Market sell-off impacts stock, down 0.53%
20 Mar: Week closes at Rs.37.73, down 0.19%

Archit Organosys Ltd Stock Falls to 52-Week Low of Rs.36.1
2026-03-17 11:25:31Archit Organosys Ltd, a micro-cap player in the Commodity Chemicals sector, has touched a new 52-week low of Rs.36.1 today, marking a significant milestone in its recent price trajectory. Despite outperforming its sector by 2.73% on the day, the stock remains under pressure, trading below all major moving averages and continuing a trend of underperformance against key benchmarks.
Read full news article
Archit Organosys Ltd is Rated Sell
2026-03-16 10:10:47Archit Organosys Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 Feb 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 16 March 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Archit Organosys Ltd Valuation Shifts to Fair Amidst Elevated Multiples
2026-03-16 08:01:03Archit Organosys Ltd, a micro-cap player in the commodity chemicals sector, has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair rating. This change reflects evolving market perceptions amid a challenging industry backdrop and a mixed performance relative to peers and benchmarks such as the Sensex.
Read full news article
Archit Organosys Ltd is Rated Sell
2026-03-02 10:10:49Archit Organosys Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 March 2026, providing investors with the latest insights into its performance and outlook.
Read full news article
Archit Organosys Ltd is Rated Sell
2026-02-15 10:10:19Archit Organosys Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 February 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Archit Organosys Ltd Valuation Shifts Signal Renewed Price Attractiveness
2026-02-11 08:01:51Archit Organosys Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating, despite ongoing sector headwinds. This change reflects evolving investor sentiment and a reassessment of the company’s price attractiveness relative to its historical and peer benchmarks within the commodity chemicals industry.
Read full news articleAre Archit Organosys Ltd latest results good or bad?
2026-02-08 19:13:20Archit Organosys Ltd has recently reported its financial results for Q3 FY26, showcasing a notable turnaround in net profit, which reached ₹2.43 crores, marking a significant improvement from the previous quarter's loss. This quarter also witnessed a revenue growth of 28.60% for the first half of FY26 compared to the same period last year, indicating strong top-line performance. However, despite these positive developments, the company continues to face significant challenges related to profitability and capital efficiency. The operating margin, excluding other income, has seen a decline to 7.69%, down from 10.48% in the previous quarter, highlighting ongoing margin compression. Additionally, the return on equity (ROE) remains critically low at 0.97%, suggesting that the company is struggling to generate adequate returns on its equity capital. This weak capital efficiency raises concerns about the sustaina...
Read full news article






